Ishara Investments’s Mereo BioPharma MREO Stock Holding History

Ishara Investments’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$244K	Buy	+768,750	New	+$231K	0.18%	40

Other funds holding MREO

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.16% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Ishara Investments's MREO Position: Q2 2026 in Review

Ishara Investments opened a new position in Mereo BioPharma (MREO) in Q2 2026: 768,750 shares worth $244K. The stake represents 0.18% of the portfolio and ranks #40 among its holdings.

56 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

Ishara Investments held 768,750 shares of Mereo BioPharma worth $244K as of Q2 2026.
Mereo BioPharma was a new Ishara Investments position in Q2 2026.
Mereo BioPharma made up 0.18% of Ishara Investments's portfolio in Q2 2026, its #40 holding.
56 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.